Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Mack

Showing results (141-150 of 170) with videos related to

Pageof 17
Sort By:
The Pediatric Infectious Disease Journal|December 27, 2021
Frequency, Characteristics and Complications of COVID-19 in Hospitalized InfantsCharlotte V Hobbs, Kate Woodworth, Cameron C Young, et al.
MMWR. Morbidity and Mortality Weekly Report|October 21, 2021
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021Samantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in ChildrenJoyce C Chang, Cameron C Young, Eyal Muscal, et al.
MMWR. Morbidity and Mortality Weekly Report|January 13, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021Laura D Zambrano, Margaret M Newhams, Samantha M Olson, et al.
Frontiers in Pediatrics|November 3, 2023
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-CAline B Maddux, Cameron C Young, Suden Kucukak, et al.
Nature Communications|August 12, 2022
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
MMWR. Morbidity and Mortality Weekly Report|October 24, 2023
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023Regina M Simeone, Laura D Zambrano, Natasha B Halasa, et al.
Nature Communications|May 27, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
The Pediatric Infectious Disease Journal|December 25, 2023
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National NetworkLaura D Zambrano, Margaret M Newhams, Regina M Simeone, et al.
Journal of the Pediatric Infectious Diseases Society|October 30, 2022
Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19Leila C Sahni, Ashley M Price, Samantha M Olson, et al.
Pageof 17

Showing results (141-150 of 170) with videos related to

Sort By:
Pageof 17
The Pediatric Infectious Disease Journal|December 27, 2021
Frequency, Characteristics and Complications of COVID-19 in Hospitalized InfantsCharlotte V Hobbs, Kate Woodworth, Cameron C Young, et al.
MMWR. Morbidity and Mortality Weekly Report|October 21, 2021
Effectiveness of Pfizer-BioNTech mRNA Vaccination Against COVID-19 Hospitalization Among Persons Aged 12-18 Years - United States, June-September 2021Samantha M Olson, Margaret M Newhams, Natasha B Halasa, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 13, 2023
Variation in Early Anakinra Use and Short-Term Outcomes in Multisystem Inflammatory Syndrome in ChildrenJoyce C Chang, Cameron C Young, Eyal Muscal, et al.
MMWR. Morbidity and Mortality Weekly Report|January 13, 2022
Effectiveness of BNT162b2 (Pfizer-BioNTech) mRNA Vaccination Against Multisystem Inflammatory Syndrome in Children Among Persons Aged 12-18 Years - United States, July-December 2021Laura D Zambrano, Margaret M Newhams, Samantha M Olson, et al.
Frontiers in Pediatrics|November 3, 2023
Risk factors for health impairments in children after hospitalization for acute COVID-19 or MIS-CAline B Maddux, Cameron C Young, Suden Kucukak, et al.
Nature Communications|August 12, 2022
Author Correction: Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
MMWR. Morbidity and Mortality Weekly Report|October 24, 2023
Effectiveness of Maternal mRNA COVID-19 Vaccination During Pregnancy Against COVID-19-Associated Hospitalizations in Infants Aged <6 Months During SARS-CoV-2 Omicron Predominance - 20 States, March 9, 2022-May 31, 2023Regina M Simeone, Laura D Zambrano, Natasha B Halasa, et al.
Nature Communications|May 27, 2022
Cross-reactive immunity against the SARS-CoV-2 Omicron variant is low in pediatric patients with prior COVID-19 or MIS-CJuanjie Tang, Tanya Novak, Julian Hecker, et al.
The Pediatric Infectious Disease Journal|December 25, 2023
Characteristics and Clinical Outcomes of Vaccine-Eligible US Children Under-5 Years Hospitalized for Acute COVID-19 in a National NetworkLaura D Zambrano, Margaret M Newhams, Regina M Simeone, et al.
Journal of the Pediatric Infectious Diseases Society|October 30, 2022
Factors Associated With COVID-19 Non-vaccination in Adolescents Hospitalized Without COVID-19Leila C Sahni, Ashley M Price, Samantha M Olson, et al.
Pageof 17